Skip to main content
Monday, November 16, 2026Nov 16

Tennessee judge sets July damages trial in opioid case

FILE - This Oct. 14, 2015 file photo shows the Food and Drug Administration campus in Silver Spring, Md. On Thursday, June 8, 2017, the FDA said it has asked Endo Pharmaceuticals to stop selling its reformulated, extended-release painkiller, Opana ER. (AP Photo/Andrew Harnik, File)
FILE - This Oct. 14, 2015 file photo shows the Food and Drug Administration campus in Silver Spring, Md. On Thursday, June 8, 2017, the FDA said it has asked Endo Pharmaceuticals to stop selling its reformulated, extended-release painkiller, Opana ER. (AP Photo/Andrew Harnik, File)

KINGSPORT, Tenn. (AP) — A Tennessee judge has set a July 26 start for a trial to decide damages against an opioid manufacturer in a lawsuit over the company’s role in the epidemic.

Sullivan County Circuit Court Chancellor E.G. Moody set the date Thursday after entering a default judgment against Endo Pharmaceutical earlier this week, a rare case of a judge making a decision before a trial was held over the company’s liability.

The judge said it was necessary because of a “coordinated strategy” by Endo and its attorneys to delay proceedings, deprive plaintiffs of information and interfere with the administration of justice. The issues surrounded the discovery phase of the case.

The company disagreed with the judge’s assessment and has said it will appeal.

The lawsuit’s plaintiffs include a child born addicted to opioids. They are seeking $2.4 billion.